Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids
European Journal of Pharmaceutics and Biopharmaceutics · 2025
DOI: 10.1016/j.ejpb.2025.114763 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2025. Verfasst von Yaqi Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, The University of Kansas, 2093 Constant Avenue, Lawrence, KS 66047, The United States of America. Hauptthemen laut MEDLINE: Polysorbates, Fatty Acids, Nonesterified, Acetates, Ferric Compounds. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 111 Literaturangaben. Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Polysorbate 80 (PS80) is a widely used nonionic surfactant in biopharmaceutical formulations. PS80 is prone to chemical degradation, potentially resulting in loss of surfactant properties essential for the stability of pharmaceutical formulations. A deep understanding of PS80 stability is critical to maintaining drug efficacy and safety. While general mechanisms of oxidation are known, specific mechanistic information on the initiation of PS80 oxidation in formulations is lacking. Here, we report on novel mechanisms of photo-degradation of PS80 in pharmaceutical buffers such as acetate, succinate, and adipate, containing Fe(III). Photo-degradation was monitored by fluorescence micelle assay (FMA) and mass spectrometry (MS). The mechanistic investigation suggests an intra-micellar PS80 photo-degradation mechanism, wherein buffer-derived carbon-centered radicals, generated from light-induced ligand-to-metal-charge-transfer (LMCT) and decomposition of Fe(III)-carboxylate complexes, enter the PS80 micelles and initiate degradation. Critical for the extent of photo-degradation is the presence of small levels of free fatty acids (FFAs), such as can be present in commercial multi-compendial PS80, facilitating the access of radicals into micelles via complexing with Fe(III) on the micelle surface.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, The University of Kansas, 2093 Constant Avenue, Lawrence, KS 66047, The United States of America.
- Biotechnology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, The United States of America.
- Bioproduct Research & Development, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, The United States of America.
- Department of Pharmaceutical Chemistry, The University of Kansas, 2093 Constant Avenue, Lawrence, KS 66047, The United States of America. Electronic address: schoneic@ku.edu.
Förderung
- Eli Lilly and Company
Zitieren
APA
Wu, Y., Richards, D., Zhang, Y., Zhang, L., Dodd, S. W., & Schöneich, C. (2025). Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114763
Vancouver
Wu Y, Richards D, Zhang Y, Zhang L, Dodd SW, Schöneich C. Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids. European Journal of Pharmaceutics and Biopharmaceutics. 2025. doi:10.1016/j.ejpb.2025.114763
BibTeX
@article{Wu2025,
author = {Wu, Yaqi and Richards, David and Zhang, Yilue and Zhang, Lin and Dodd, Steve W and Schöneich, Christian},
title = {Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2025},
doi = {10.1016/j.ejpb.2025.114763}
}
EUVIMED